ArticleBMC primary care2025
Association between polypharmacy and hypertension in the Iranian population aged 50 years or older: Iranian Multicenter Osteoporosis Study (IMOS-2021).
Article in BMC primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundHypertension is a major global health concern associated with chronic conditions, particularly in aged adults. Managing these conditions often requires multiple medications, raising the risk of polypharmacy. This study evaluates the association between polypharmacy and blood pressure (BP) status among hypertensives versus normotensives, also analyzing demographic and comorbidity factors.
methodsThis cross-sectional population-based study examined data from the national Iranian Multicenter Osteoporosis Study (IMOS-2021), which utilized a multi-stage random sampling to gather data of aged ≥ 50 years. Polypharmacy and hypertension (HTN) were defined as the use of ≥ 3 or ≥ 5 medications, and systolic BP (SBP) ≥ 140 and diastolic BP (DBP) ≥ 90 mmHg, respectively. Multiple logistic regression models were used to assess the association. Fully adjusted model was including age, sex, waist circumference, residencial area, employment, education, alcohol consumption, and smoking.
resultsThis study of 1,368 Iranians found a higher association between polypharmacy and HTN versus normotension (≥ 3 drugs: 43.03% vs. 17.93% ; ≥5 drugs: 19.95% vs. 6.01%). This association was more prevalent among older adults, females, rural residents, and those with ≥ 2 comorbidities. Uncontrolled HTN was significantly linked to increased medication use (adjusted Odds Ratio 1.15 per added drug).
conclusionsDue to the significant association between polypharmacy and HTN, especially uncontrolled HTN, in older adults, physicians should be aware of the potential adverse effect of unnecessary prescriptions on the health of aged HTN patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.